According to reports, drawing on its strengths in disciplines such as pharmaceutical sciences, WMU has long maintained an internationally leading position in basic FGF research and translational applications. Through more than three decades of dedicated work, Academician Li Xiaokun’s team has enabled China to become the first country in the world to successfully develop growth factors into clinical drugs. During the visit to Malta, through a series of initiatives including academic presentations and exchanges, alliance development seminars, the launch of an international journal, and the release of open research projects, WMU established an integrated international cooperation network in the global FGF research field that brings together mechanisms, platforms, and resources. Looking ahead, the university will continue to advance frontier research in biomedicine and make greater contributions to promoting scientific and technological progress in life and health and serving the country’s overarching strategic priorities.

Article from: People's Daily